-

Investor Notice: Robbins LLP Informs Investors of the Apollo Global Management, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Apollo Global Management, Inc. (NYSE: APO) securities between May 10, 2021 and February 21, 2026. Apollo Global describes itself as a “high-growth, global alternative asset manager and a retirement services provider.”

Robbins LLP is Investigating Allegations that Apollo Global Management, Inc. (APO) Failed to Disclose to Investors that Jeffrey Epstein was Involved in the Company's Business

Share

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Apollo Global Management, Inc. (APO) Failed to Disclose to Investors that Jeffrey Epstein was Involved in the Company's Business

According to the complaint, during the class period defendants failed to disclose that: (1) defendants Rowan and Black, among other leadership figures at Apollo Global, frequently communicated with Jeffrey Epstein in the 2010s regarding Apollo Global’s business; (2) as a result, Apollo Global’s assertion that the Company had never done business with Jeffrey Epstein was untrue; (3) because of the entanglement between Apollo Global’s leaders and Jeffrey Epstein, the harm to Apollo Global’s reputation was more than a mere possibility; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

Plaintiff alleges that on February 1, 2026, The Financial Times published an article titled, "Apollo chief Marc Rowan consulted Epstein on firm's tax affairs." The article provided details on the various ways in which Jeffrey Epstien was involved in Apollo Global's business. On this news, the price of Apollo Global stock fell $1.35 per share to close at $133.19 on February 2, 2026. Apollo Global share prices continued to drop and, on February 3, 2026, Apollo Global share prices dropped an additional $6.34 to close at $126.85. Plaintiff further alleges that on February 17, 2026, The Financial Times published an article titled, "SEC urged to investigate Apollo over Epstein ties." On this news, Apollo Global share prices dropped from closing on February 17, 2026 at $125.15 to $118.34, a drop of $6.81 over two trading days. Finally, on February 21, 2026, CNN published an articled titled, "How Wall Street's Apollo got tangled up again in the Epstein files." On this news, Apollo Group shares dropped by $5.99, or approximately 5%, to close at $113.73 on February 23, 2026.

What Now: You may be eligible to participate in the class action against Apollo Global Management, Inc. Shareholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Apollo Global Management Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:APO

Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Robbins LLP Urges DNB Stockholders Who Lost Money Investing in Dun & Bradstreet Holdings, Inc. to Contact the Firm for Information About Leading the Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of sellers of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) common stock between May 13, 2025 and August 26, 2025, inclusive (the “Class Period”), including holders who exchanged shares of Dun & Bradstreet common stock in the Merger with Clearlake Capital Group, L.P., and holders of Dun & Bradstreet common stock as of the May 9, 2025 record date for the special...

Portillo's Inc. Securities Violation Investigation - Robbins LLP is Investigating the Officers and Directors of PTLO for Breaches of Fiduciary Duty and Violations of Securities Laws

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Portillo’s Inc. (NASDAQ: PTLO) to determine whether certain Portillo's Inc. officers and directors violated securities laws and breached fiduciary duties to shareholders. Portillo's Inc. owns and operates fast casual restaurants in the United States. Why Are We Investigating Portillo's? On August 5, 2025, Portillo's reported second quarter 2025 financial results. Although the Company maintained its target of 12...

Robbins LLP Urges DOCS Stockholders Who Lost Money Investing in Doximity, Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024 and May 13, 2026, inclusive (the "Class Period"). Doximity is a digital platform for medical professionals that combines health care news, workflow products, and clinician networking. The complaint alleges that Doximity failed to disclose to investo...
Back to Newsroom